Clare Whitehead
@clwhitehead.bsky.social
Clinical academic researching pregnancy complications and prematurity
PI for PLATIPUS trial @platipus.bsky.social
Adaptive trials
Fetal Medicine subspecialist
British Canadian in Australia
PI for PLATIPUS trial @platipus.bsky.social
Adaptive trials
Fetal Medicine subspecialist
British Canadian in Australia
Reposted by Clare Whitehead
So excited to share our commentary out now in LancetCAH and freely available via the link below!
The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social
url.au.m.mimecastprotect.com/s/ukzLCmOxr6...
The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social
url.au.m.mimecastprotect.com/s/ukzLCmOxr6...
url.au.m.mimecastprotect.com
January 23, 2025 at 12:24 AM
So excited to share our commentary out now in LancetCAH and freely available via the link below!
The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social
url.au.m.mimecastprotect.com/s/ukzLCmOxr6...
The time is NOW for Adaptive Platform Trials to improve outcomes for preterm infants! @platipus.bsky.social
url.au.m.mimecastprotect.com/s/ukzLCmOxr6...
Reposted by Clare Whitehead
We're pleased to share our first animation, that aims to grow potential participant awareness of PLATIPUS and how it works.
Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this.
www.platipustrial.org/participants...
Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this.
www.platipustrial.org/participants...
May 7, 2025 at 5:57 AM
We're pleased to share our first animation, that aims to grow potential participant awareness of PLATIPUS and how it works.
Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this.
www.platipustrial.org/participants...
Special thanks to Stephanie Hebbard, Kelly Fredell, Tara Lofhelm, PLATIPUS Lived Experience Committee and others who helped create this.
www.platipustrial.org/participants...
Reposted by Clare Whitehead
Have you read our article about adaptive platform trials for preterm birth yet? #neosky
We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field.
Are APTs the answer?
www.thelancet.com/journals/lan...
We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field.
Are APTs the answer?
www.thelancet.com/journals/lan...
Adapt to survive and thrive: the time is now for adaptive platform trials for preterm birth
In this Viewpoint, we discuss the challenges facing perinatal clinical researchers,
many of which are unique to this field, and how traditional two-arm randomised trials
using frequentist analysis mig...
www.thelancet.com
March 20, 2025 at 9:54 PM
Have you read our article about adaptive platform trials for preterm birth yet? #neosky
We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field.
Are APTs the answer?
www.thelancet.com/journals/lan...
We discuss the challenges facing perinatal clinical researchers and how traditional RCTs may no longer be fit for purpose in our field.
Are APTs the answer?
www.thelancet.com/journals/lan...
Reposted by Clare Whitehead
Cytomegalovirus (CMV) is the leading cause of infectious birth defects and linked to many other morbidities such as with transplantation. For the first time after >50 years of pursuit, a vaccine is in reach jci.org/articles/vie...
January 5, 2025 at 4:14 PM
Cytomegalovirus (CMV) is the leading cause of infectious birth defects and linked to many other morbidities such as with transplantation. For the first time after >50 years of pursuit, a vaccine is in reach jci.org/articles/vie...
Such a huge amount of work - the PLUSS trial published in JAMA by our own @drbretty.bsky.social
If you haven’t caught up on the PLUSS trial results yet, published a few days ago in JAMA #neosky #nicusky
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants
This randomized trial assesses the effect of intratracheal budesonide mixed with surfactant on survival free of bronchopulmonary dysplasia in extremely preterm infants.
jamanetwork.com
November 27, 2024 at 10:10 AM
Such a huge amount of work - the PLUSS trial published in JAMA by our own @drbretty.bsky.social
Exciting times ahead leading the PLATIPUS trial with @drbretty.bsky.social
Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains:
1. PROMOAT - best choice of ABx for PPROM
2. BabyCCINO - which caffeine citrate dose for very preterm infants
#NeoSky #NICUSky #ObGynSky
Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains:
1. PROMOAT - best choice of ABx for PPROM
2. BabyCCINO - which caffeine citrate dose for very preterm infants
#NeoSky #NICUSky #ObGynSky
November 27, 2024 at 10:09 AM
Exciting times ahead leading the PLATIPUS trial with @drbretty.bsky.social
Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains:
1. PROMOAT - best choice of ABx for PPROM
2. BabyCCINO - which caffeine citrate dose for very preterm infants
#NeoSky #NICUSky #ObGynSky
Follow us or @platipus.bsky.social for updates on the PLATIPUS & its first 2 domains:
1. PROMOAT - best choice of ABx for PPROM
2. BabyCCINO - which caffeine citrate dose for very preterm infants
#NeoSky #NICUSky #ObGynSky
Great to see progress in stillbirth reduction - but so much still to be done
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
Despite the gradual global decline in stillbirths between 1990 and 2021, the overall
number of stillbirths remains substantially high. Counting all stillbirths is paramount
to progress, as nearly a th...
www.thelancet.com
November 27, 2024 at 10:04 AM
Great to see progress in stillbirth reduction - but so much still to be done
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
Well done Robyn and Della. It’s so important we maintain a skilled midwifery workforce to keep our patients safe and optimise outcomes.
"I love my job. But it’s physically, mentally, & emotionally draining”: a cross-sectional survey exploring midwives’ intentions of leaving the profession
Robyn Matthews, Michelle Newton, Rebecca Hyde, Touran Shafiei, Fleur Llewelyn & Della Forster
bmchealthservres.biomedcentral.com/articles/10....
Robyn Matthews, Michelle Newton, Rebecca Hyde, Touran Shafiei, Fleur Llewelyn & Della Forster
bmchealthservres.biomedcentral.com/articles/10....
I love my job. But it’s physically, mentally, and emotionally draining”: a cross-sectional survey exploring midwives’ intentions of leaving the profession in Melbourne, Australia - BMC Health Services...
Background Prior to the COVID-19 pandemic there were midwifery workforce deficits reported in Australia, but inadequate workforce data to identify retention and attrition in the profession. In the pos...
bmchealthservres.biomedcentral.com
November 27, 2024 at 9:35 AM
Well done Robyn and Della. It’s so important we maintain a skilled midwifery workforce to keep our patients safe and optimise outcomes.